Estradiol Cyp recalls
The FDA has published 2 recalls involving Estradiol Cyp since 2013. The latest was reported on 1 Feb 2023. Most were for sterility. Pharmacy Innovations has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2013
Last 12 months0reported
Class I00% of total
Ongoing0latest 1 Feb 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why estradiol cyp is recalled
Companies
By year
All estradiol cyp recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Estradiol Cyp/test Cyp- Ss Oil- 2mg/50mg/ML Vial) Injectable recalled | Pharmacy Innovations | Sterility | Nationwide |
| Drug | CLASS II | Estradiol Cyp/Prog/Test Cyp 0.5/10/10 MG/ML Oil Inj Soln recalled | Beacon Hill Medical Pharmacy, P.C | Sterility | Nationwide |
Should you stop taking Estradiol Cyp?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.